These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9. Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610 [TBL] [Abstract][Full Text] [Related]
9. Surgical operation in hemophilia B. Use of factor IX concentrate. Kasper CK Calif Med; 1970 Jul; 113(1):4-8. PubMed ID: 5520728 [TBL] [Abstract][Full Text] [Related]
10. Molecular genotyping of the Italian cohort of patients with hemophilia B. Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G; Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378 [TBL] [Abstract][Full Text] [Related]
11. [Coagulation factor IX inhibitor in hemophilia B]. Lutze G; Mittler U; Presser HJ; Urbahn H Z Med Lab Diagn; 1990; 31(2):113-9. PubMed ID: 2343619 [TBL] [Abstract][Full Text] [Related]
12. [Ulcerative colitis and hemophilia B]. Rodríguez Cuartero A; González Martínez F; Salas Galán A Rev Esp Enferm Dig; 1997 Jul; 89(7):573-4. PubMed ID: 9303627 [No Abstract] [Full Text] [Related]
13. [Factor IX and factor IX inhibitor]. Higasa S Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413 [No Abstract] [Full Text] [Related]
14. Platelets: a new target for gene therapy of haemophilia B. Brown MA Thromb Haemost; 2002 Mar; 87(3):362-3. PubMed ID: 11916064 [No Abstract] [Full Text] [Related]
15. Prosthetic heart valves and rare hypersensitivity to vitamin K antagonists resulting from factor IX mutation: how to manage anticoagulation? Holbro A; Marbet GA; Tran TH; Oldenburg J; Friesewinkel O; Tsakiris DA Haemophilia; 2010 Jan; 16(1):187-9. PubMed ID: 19804386 [No Abstract] [Full Text] [Related]
16. [Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)]. Sugimoto M; Fujimura Y; Okubo Y; Takahashi Y; Yoshioka A; Fukui H Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1181-9. PubMed ID: 6516702 [No Abstract] [Full Text] [Related]
17. Factor IX: Insights from knock-out and genetically engineered mice. Monahan PE Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277 [TBL] [Abstract][Full Text] [Related]
18. An unusual presentation of hemophilia B: pseudotumor of proximal tibia. Mittal S; Arora S; Khanna S; Maini L; Gautam VK Am J Orthop (Belle Mead NJ); 2011 Jul; 40(7):E138-40. PubMed ID: 22013580 [TBL] [Abstract][Full Text] [Related]
19. Editorial: Clinical concentrates of clotting-factor IX. Lancet; 1975 Nov; 2(7940):855-6. PubMed ID: 53334 [No Abstract] [Full Text] [Related]
20. [Molecular diagnosis in patients and carriers of hemophilia A and B]. Mantilla-Capacho J; Beltrán-Miranda CP; Jaloma-Cruz AR Gac Med Mex; 2005; 141(1):69-71. PubMed ID: 15754755 [No Abstract] [Full Text] [Related] [Next] [New Search]